The post YZi Labs Backs Genius as Trading Shifts Onchain appeared on BitcoinEthereumNews.com. YZi Labs, an independent investment firm led by Binance founder ChangpengThe post YZi Labs Backs Genius as Trading Shifts Onchain appeared on BitcoinEthereumNews.com. YZi Labs, an independent investment firm led by Binance founder Changpeng

YZi Labs Backs Genius as Trading Shifts Onchain

YZi Labs, an independent investment firm led by Binance founder Changpeng “CZ” Zhao, has invested in onchain trading terminal Genius Trading, highlighting growing investor attention on cross-chain trading infrastructure.

While financial terms were not disclosed, YZi Labs said Tuesday that it made an eight-figure investment in the company. Zhao is also joining Genius Trading as an adviser, according to the announcement.

The investment suggests that cross-chain trading terminals are increasingly being viewed as core market infrastructure rather than purely user-facing tools, as activity continues to spread across multiple blockchains and liquidity venues. 

Genius Trading is not a decentralized exchange, but a trading interface designed to aggregate execution across blockchains and decentralized venues. The investment points to increasing emphasis on execution-focused infrastructure, such as routing, performance and workflow tools for large traders, rather than liquidity alone.

Source: YZi Labs

Genius said it has processed more than $160 million in trading volume across ten blockchains prior to launch. Tuesday’s announcement also marked the platform’s public debut, with support for spot trading, perpetual futures and copy trading.

YZi Labs manages approximately $10 billion in assets and focuses on venture-stage investments across Web3, artificial intelligence and biotechnology. The firm operates as Zhao’s family office and evolved from Binance’s former venture arm.

Related: Binance expands into precious metals with gold, silver futures settled in USDT

Emergence of trading terminals in DeFi

As decentralized finance has expanded across multiple blockchains, cross-chain trading has become increasingly important, enabling traders to move and manage assets across different networks. 

Much of the focus to date has been on cross-chain functionality within decentralized exchanges (DEXs), while trading terminals have emerged as a separate category — software interfaces that connect to multiple venues and chains to support more advanced trading workflows.

YZi Labs highlighted this shift in its announcement, noting that a growing share of trading activity is moving from centralized exchanges (CEXs) to decentralized venues. While this transition offers greater transparency and self-custody, the firm said it also introduces what it described as a “transparency bug,” referring to the difficulty of executing large trades on public blockchains without signaling intent to the broader market.

The DEX-to-CEX spot volume ratio peaked last June but has continued to trend upward as more crypto trading volume is being facilitated on decentralized exchanges. Source: CoinGecko

YZi Labs cited this dynamic as one of the reasons it backed Genius Trading, which aims to consolidate trading across major blockchain networks while prioritizing execution quality and privacy for professional traders.

Related: Crypto enters round 2 of institutional adoption, led by Morgan Stanley: Binance

Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently. Read our Editorial Policy https://cointelegraph.com/editorial-policy

Source: https://cointelegraph.com/news/yzi-labs-investment-genius-cross-chain-trading-terminal?utm_source=rss_feed&utm_medium=feed&utm_campaign=rss_partner_inbound

Market Opportunity
CROSS Logo
CROSS Price(CROSS)
$0.10905
$0.10905$0.10905
-0.96%
USD
CROSS (CROSS) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

A whale that made a 141% profit on PUMP three days ago bought 321 million TRUMPs today, with a floating profit of $223,000.

A whale that made a 141% profit on PUMP three days ago bought 321 million TRUMPs today, with a floating profit of $223,000.

PANews reported on September 18th that according to Lookonchain monitoring, whale H56YMH sold 317 million PUMPs (worth approximately $2.53 million) at an average price of $0.008 three days ago, realizing a net profit of $1.48 million (a 141% return). Subsequently, eight hours ago, it purchased 321 million TRUMPs at an average price of $0.007835, resulting in unrealized profits of $223,000.
Share
PANews2025/09/18 10:36
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11
Silver Price Crash Is Over “For Real This Time,” Analyst Predicts a Surge Back Above $90

Silver Price Crash Is Over “For Real This Time,” Analyst Predicts a Surge Back Above $90

Silver has been taking a beating lately, and the Silver price hasn’t exactly been acting like a safe haven. After running up into the highs, the whole move reversed
Share
Captainaltcoin2026/02/07 03:15